Galectin Therapeutics Inc (NASDAQ:GALT)

2.70
Delayed Data
As of 1:45pm ET
 +0.08 / +3.05%
Today’s Change
2.52
Today|||52-Week Range
16.55
-22.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-10.9M-9.3M-12.1M-15.8M
 
 
 
 
 
Depreciation9.0K9.0K12.0K10.0K
 
 
 
 
 
Total Other Cash Flow3.8M2.4M3.8M4.5M
 
 
 
 
 
Funds From Operations-7.1M-6.9M-8.3M-11.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.5M626.0K-809.0K1.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-5.7M-7.5M-7.5M-12.4M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-400.0K
 
 
Capital Expenditures-5.0K-5.0K0.000.00
 
 
 
Other Investing - Uses-10.0K0.000.000.00
 
 
Other Investing - Sources0.0069.0K0.000.00
 
 
Net Cash Flow Investing-15.0K64.0K0.00-400.0K
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale6.2M10.4M8.6M31.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing6.2M10.4M8.6M31.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash506.0K3.0M1.1M18.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account